Contrast induced nephropathy epidemiology and demographics
|
Contrast Induced Nephropathy Microchapters |
|
Differentiating Contrast induced nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Contrast induced nephropathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Contrast induced nephropathy epidemiology and demographics |
|
FDA on Contrast induced nephropathy epidemiology and demographics |
|
CDC on Contrast induced nephropathy epidemiology and demographics |
|
Contrast induced nephropathy epidemiology and demographics in the news |
|
Blogs on Contrast induced nephropathy epidemiology and demographics |
|
Directions to Hospitals Treating Contrast induced nephropathy |
|
Risk calculators and risk factors for Contrast induced nephropathy epidemiology and demographics |
Overview
Contrast media are responsible for 11% of cases of hospital-acquired renal insufficiency, the third most common cause of renal failure, The overall mortality rate was 19.4% and was similar among patients for all causes of renal insufficiency. [1]
Epidemiology and Demographics
Decline in renal function remains a common event despite the improvement in the care of hospitalized patients. An overall incidence of CIN in the general population is reported to be 0.6–2.3%.[2] Contrast media are responsible for 11% of cases of hospital-acquired renal insufficiency, the third most common cause of renal failure after impaired renal perfusion and the use of nephrotoxic medications. The overall mortality rate was 19.4% and was similar among patients for all causes of renal insufficiency, except sepsis. [1] An overall incidence of CIN in the general population is reported to be 0.6–2.3%
References
- ↑ 1.0 1.1 Nash K, Hafeez A, Hou S (2002). "Hospital-acquired renal insufficiency". Am J Kidney Dis. 39 (5): 930–6. doi:10.1053/ajkd.2002.32766. PMID 11979336.
- ↑ Lasser EC, Lyon SG, Berry CC (1997). "Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration". Radiology. 203 (3): 605–10. PMID 9169676.